These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36688928)

  • 1. An Integrated Algorithm for Differentiating Hypertrophic Cardiomyopathy From Hypertensive Heart Disease.
    Kong LC; Wu LM; Wang Z; Liu C; He B
    J Magn Reson Imaging; 2023 Oct; 58(4):1084-1097. PubMed ID: 36688928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Combination of Feature Tracking and Late Gadolinium Enhancement for Identification Between Hypertrophic Cardiomyopathy and Hypertensive Heart Disease.
    Liu S; Li Y; Zhao Y; Wang X; Wu Z; Gu X; Xu B; Li Y; Tian J; Cui J; Wang G; Yu B
    Front Cardiovasc Med; 2022; 9():865615. PubMed ID: 35647085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertensive heart disease versus hypertrophic cardiomyopathy: multi-parametric cardiovascular magnetic resonance discriminators when end-diastolic wall thickness ≥ 15 mm.
    Rodrigues JC; Rohan S; Ghosh Dastidar A; Harries I; Lawton CB; Ratcliffe LE; Burchell AE; Hart EC; Hamilton MC; Paton JF; Nightingale AK; Manghat NE
    Eur Radiol; 2017 Mar; 27(3):1125-1135. PubMed ID: 27368925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular magnetic resonance feature tracking strain analysis for discrimination between hypertensive heart disease and hypertrophic cardiomyopathy.
    Neisius U; Myerson L; Fahmy AS; Nakamori S; El-Rewaidy H; Joshi G; Duan C; Manning WJ; Nezafat R
    PLoS One; 2019; 14(8):e0221061. PubMed ID: 31433823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left ventricular structure and diastolic function by cardiac magnetic resonance imaging in hypertrophic cardiomyopathy.
    Chacko BR; Karur GR; Connelly KA; Yan RT; Kirpalani A; Wald R; Jimenez-Juan L; Jacob JR; Deva DP; Yan AT
    Indian Heart J; 2018; 70(1):75-81. PubMed ID: 29455792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy: The Utility of Myocardial Strain Based on Cardiac MR Tissue Tracking.
    She JQ; Guo JJ; Yu YF; Zhao SH; Chen YY; Ge MY; Zeng MS; Jin H
    J Magn Reson Imaging; 2021 Jan; 53(1):51-60. PubMed ID: 32798304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histogram Analysis of Native T
    Wu CW; Wu R; Shi RY; An DA; Chen BH; Jiang M; Bacyinski A; Rahim A; Deen JM; Hu J; Han TT; Xu JR; Wu LM
    J Magn Reson Imaging; 2019 Mar; 49(3):668-677. PubMed ID: 30142234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deep Learning for Discrimination of Hypertrophic Cardiomyopathy and Hypertensive Heart Disease on MRI Native T1 Maps.
    Wang ZC; Fan ZZ; Liu XY; Zhu MJ; Jiang SS; Tian S; Chen BH; Wu LM
    J Magn Reson Imaging; 2024 Mar; 59(3):837-848. PubMed ID: 37431848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-parametric assessment of left ventricular hypertrophy using late gadolinium enhancement, T1 mapping and strain-encoded cardiovascular magnetic resonance.
    Giusca S; Steen H; Montenbruck M; Patel AR; Pieske B; Erley J; Kelle S; Korosoglou G
    J Cardiovasc Magn Reson; 2021 Jul; 23(1):92. PubMed ID: 34247623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic and Prognostic Value of Cardiac Magnetic Resonance Strain in Suspected Myocarditis With Preserved LV-EF: A Comparison Between Patients With Negative and Positive Late Gadolinium Enhancement Findings.
    Chen Y; Sun Z; Xu L; Liu J; Li Y; Zhang N; Liu D; Wen Z
    J Magn Reson Imaging; 2022 Apr; 55(4):1109-1119. PubMed ID: 34369030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left atrial fibrosis correlates with extent of left ventricular myocardial delayed enhancement and left ventricular strain in hypertrophic cardiomyopathy.
    Latif SR; Nguyen VQ; Peters DC; Soufer A; Henry ML; Grunseich K; Testani J; Hur DJ; Huber S; Mojibian H; Dicks D; Sinusas AJ; Meadows JL; Papoutsidakis N; Jacoby D; Baldassarre LA
    Int J Cardiovasc Imaging; 2019 Jul; 35(7):1309-1318. PubMed ID: 30790116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnostic value of multiparameter cardiovascular magnetic resonance for early detection of light-chain amyloidosis from hypertrophic cardiomyopathy patients.
    Yue X; Yang L; Wang R; Chan Q; Yang Y; Wu X; Ruan X; Zhang Z; Wei Y; Wang F
    Front Cardiovasc Med; 2022; 9():1017097. PubMed ID: 36330005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertrophic cardiomyopathy and left ventricular hypertrophy in hypertensive heart disease with mildly reduced or preserved ejection fraction: insight from altered mechanics and native T1 mapping.
    Wu LM; An DL; Yao QY; Ou YZ; Lu Q; Jiang M; Xu JR
    Clin Radiol; 2017 Oct; 72(10):835-843. PubMed ID: 28552325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI differentiation of cardiomyopathy showing left ventricular hypertrophy and heart failure: differentiation between cardiac amyloidosis, hypertrophic cardiomyopathy, and hypertensive heart disease.
    Takeda M; Amano Y; Tachi M; Tani H; Mizuno K; Kumita S
    Jpn J Radiol; 2013 Oct; 31(10):693-700. PubMed ID: 23996116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiomic Analysis of Native T
    Wang J; Yang F; Liu W; Sun J; Han Y; Li D; Gkoutos GV; Zhu Y; Chen Y
    J Magn Reson Imaging; 2020 Dec; 52(6):1714-1721. PubMed ID: 32525266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of longitudinal and circumferential contraction in relation to late gadolinium enhancement in hypertrophic cardiomyopathy patients with preserved left ventricular ejection fraction.
    Sakamoto K; Oyama-Manabe N; Manabe O; Aikawa T; Kikuchi Y; Sasai-Masuko H; Naya M; Kudo K; Kato F; Tamaki N; Shirato H
    Jpn J Radiol; 2018 Feb; 36(2):103-112. PubMed ID: 29119456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Obesity on Left Ventricular Remodeling and Clinical Outcome in Chinese Patients With Hypertrophic Cardiomyopathy: Assessed by Cardiac MRI.
    Shi K; Huang S; Li X; Xu HY; Yang MX; Li Y; Guo YK; Yang ZG
    J Magn Reson Imaging; 2023 Mar; 57(3):800-809. PubMed ID: 35715897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of global and regional myocardial mechanics with 3-dimensional speckle tracking echocardiography and relations to hypertrophy and fibrosis in hypertrophic cardiomyopathy.
    Urbano-Moral JA; Rowin EJ; Maron MS; Crean A; Pandian NG
    Circ Cardiovasc Imaging; 2014 Jan; 7(1):11-9. PubMed ID: 24275954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The association between cardiac mr feature tracking strain and myocardial late gadolinium enhancement in patients with hypertrophic cardiomyopathy].
    Ozden O; Unlu S; Kilic DI; Sherif SA; Opan S; Kemal HS; Ozmen E; Tuner H; Bingol G; Barutcu A; Nasifov M; Bakan S; Goktekin O
    Kardiologiia; 2023 Feb; 63(2):52-58. PubMed ID: 36880144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Cardiac Magnetic Resonance Feature Tracking (CMR-FT) Analysis for Detection of Myocardial Fibrosis in Pediatric Hypertrophic Cardiomyopathy.
    Bogarapu S; Puchalski MD; Everitt MD; Williams RV; Weng HY; Menon SC
    Pediatr Cardiol; 2016 Apr; 37(4):663-73. PubMed ID: 26833321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.